An Inhibitory Aptamer Against PDGF-C Overcomes Anti-VEGF Refractoriness and Reduces Choroidal Neovascularization and Fibrosis. [PDF]
Chen R +28 more
europepmc +1 more source
Exploratory assessment of bleeding risk associated with concurrent use of Anti-VEGF agents and anticoagulants in oncology. [PDF]
Liao D +5 more
europepmc +1 more source
Beyond anti-VEGF: expanding the therapeutic horizon and biomarker landscape in retinopathy of prematurity. [PDF]
Zhang Y, Chen Q, Lv J.
europepmc +1 more source
Cost Analysis of Anti-VEGF With Laser Photocoagulation in the Treatment of Retinopathy of Prematurity at an Academic Referral Center. [PDF]
Patel NA +5 more
europepmc +1 more source
Refractive outcomes following anti-VEGF, vitrectomy, cryotherapy, and laser photocoagulation for retinopathy of prematurity: a systematic review and meta-analysis. [PDF]
Huang YT +5 more
europepmc +1 more source
"Brake" and "accelerator": revisiting tumor cell direct responses and the paradox of aggression in anti-VEGF therapy. [PDF]
Wei P +5 more
europepmc +1 more source
Comparison of the efficacy of subthreshold micropulse laser versus intravitreal anti-VEGF therapy for chronic central serous chorioretinopathy. [PDF]
Li J +5 more
europepmc +1 more source
Myocardial Infarction, Stroke, and Death after Intravitreal Injection of Anti-VEGF in a Nationwide Study. [PDF]
Conese C +8 more
europepmc +1 more source
Anti-VEGF Agents and the Inner Retina in nAMD: A Narrative Review of RNFL and Ganglion Cell Changes. [PDF]
Tsiropoulos GN +3 more
europepmc +1 more source
The efficacy and safety of intraocular anti-VEGF injections versus anti-VEGF combined with steroids or steroid monotherapy for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis of randomized controlled trials. [PDF]
Cai H, Tian M, Huang Z, Wang B.
europepmc +1 more source

